CellaVision AB (publ), which develops and sells digital morphology products for the routine analysis of blood and other body fluids, is qualified for and will be placed on the NASDAQ OMX new special segment, First North Premier. Trading in CellaVision shares on NASDAQ OMX First North Premier will commence on Monday the 16th of February 2009. The listing on First North Premier requires the company to comply with higher disclosure and accounting standards than the regular First North rules. This imposes higher demands on transparency which brings benefits to both listed companies and investors. During the last five years CellaVision has been showing strong sales growth and the company reported positive result for the first time for the year 2007. The hospital demand for efficiency is a strong driving force, and the customer base today consists of laboratories mainly in Europe and North America. CellaVision shares will be traded using the short name CEVI. Certified Adviser for CellaVision is Remium AB. For more information, please contact: Yvonne Mårtensson, CEO, CellaVision AB Phone: +46 708 33 77 82. E-mail: yvonne.martensson@cellavision.com Lars Gatenbeck, Chairman of the Board, CellaVision AB Phone: +46 705 35 44 44. E-mail: lars.gatenbeck@GZgroup.se About CellaVision CellaVision AB develops, markets, and sells market leading image analysis based systems for routine analysis of blood and other body fluids. The company has a core competence in development of software and hardware for automatic image analysis of cells and cell changes for applications in health and medical care. The company develops and markets systems for automatic differentials of white blood cells and red morphology, and software for education and quality assurance of differentials. The company's associates have expertise in advanced imaging analysis, artificial intelligence, and automated microscopy. The company headquarters are in Lund, Sweden. The company also has subsidiaries in Florida, USA, Toronto, Canada and Yokohama, Japan. For more information, visit www.cellavision.com. CellaVision's share is listed on First North at the OMX Stockholm Stock Exchange. The company's Certified Advisor is Remium AB.